Mycobacteria and sarcoidosis

Thorax

Volumn 52, Issue SUPPL. 3, 1997, Pages

  Kon, O M ^a   Du Bois, R M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MYCOBACTERIUM ANTIGEN;

ACID FAST BACTERIUM; ANTERIOR EYE CHAMBER; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SARCOIDOSIS; TRACHEOBRONCHIAL TOILET;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; HUMANS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SARCOIDOSIS; SPHEROPLASTS;

EID: 0030804595     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Hutchinson J. Cases of Mortimer's malady. Arch Surg 1898;9:307-14.
2. Brennan NJ, Crean P, Long JP, Fitzgerald MX. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984;39:14-8.
3. Pasturenzi L, Martinetti M, Cuccia M, Cipriani A, Semenzato G, Luisetti M. HI-A class 1, II, and III polymorphism in Italian patients with sarcoidosis. The Pavia-Padova Sarcoidosis Study Group. Chest 1993;104:1170-5.
4. Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y, et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 1994;43:238-41.
5. Ishihara M, Ishida T, Inoko H, Ando H, Naruse T, Nose Y, et al. HLA serological and class II genotyping in sarcoidosis patients in Japan. Japanese J Ophthalmol 1996;40:86-94.
6. Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8 + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994;91:4965-9.
7. Cummings MM, Hudgins PC. Chemical constituents of pine pollens and their possible relationship to sarcoidosis. Am J Med Sci 1958;236:311-7.
8. Cummings MM. An evaluation of the possible relationship of pine pollen to sarcoidosis (a critical summary). Acta Med Scand Suppl 1964;425:48-50.
9. Buck AA, Sartwell PK. Epidemiologie investigations of sarcoidosis: II. Skin sensitivity and enviromental factors. Am J Hyg 1961;74:152-73.
10. Farber HW, Fairman RP, Glauser FL. Talc granulomatosis: laboratory findings similar to sarcoidosis. Am Rev Respir Dis 1982;125:258-61.
11. Fayemi AO, Ali M. Sarcoid-like granulomas in secondary oxalosis: a case report. Mt Sinai J Med 1980;47:255- 7.
12. Williams WJ. Beryllium disease: pathology and diagnosis. J Soc Occup Med 1977;27:93-6.
13. Shelley WB, Hurley HL. The allergic origin of zirconium deodorant granulomas. Br J Dermatol 1958;70:75-101.
14. Burke WM, Keogh A, Maloney PJ, Delprado W, Bryant DH, Spratt P. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990;336:1579.
15. Heyll A, Meckenstock G, Aul C, Sohngen D, Borchard F, Hadding U, et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;14:161-4.
16. Iwai K, Takahashi S. Transmissibility of sarcoid-specific granulomas in the footpads of mice. Ann NY Acad Sci 1976;278:249-59.
17. Mitchell DN, Rees RJ, Goswami KK. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet 1976;ii:761-5.
18. Lofgren S, Lundback H. Isolation of virus from 6 cases of saroidosis: preliminary report. Acta Med Scand 1950;138:71-5.
19. Sodja J, Votava L. Isolation of haemasorptive virus from cases of sarcoidosis. Acta Virol 1966;10:81.
20. Fillet AM, Raguin G, Agut H, Boisnic S, Agbo-Godeau S, Robert C. Evidence of human herpesvirus 6 in Sjogren syndrome and sarcoidosis. Eur J Clin Microbiol Infect Dis 1992;11:564-6.
21. James DG, Neville E. Pathobiology of sarcoidosis. Pathobiol Ann 1977;7:31-6.
22. Uesaka I, Izumi T, Tsuji S. Nocardia-like organisms isolated from lesions of sarcoidosis. In: Iwai K, Hosoda Y, eds. Procedings 6th International Conference on Sarcoidosis. Tokyo: University of Tokyo Press, 1974: 3.
23. Manz HJ. TI Pathobiology of neurosarcoidosis and clinicopathologic correlation. Can J Neurol Sci 1983;10:50-5.
24. Lipsky BA, Goldberger AC, Tomkins LS, Plorde JJ. Infections caused by nondipththeria corynebacteria. Rev Infect Dis 1982;4:1220-35.
25. Fick RB, Reynolds HY. Changing spectrum of pneumonia: new media creation or clinical reality? Am J Med 1983;74:1-8.
26. 2b Wirostko E, Johnson L, Wirostko B. Sarcoidosis associated uveitis. Parasitization of vitreous leucocytes by mollicute-like organisms. Acta Opthalmol 1989;67:415-24.
27. Wirostko E, Johnson L, Wirostko W. Mouse interstitial lung disease and pleuritis: induction by human mollicute-like organisms. Br J Exp Pathol 1988;69:891-902.
28. Johnson LA, Edsall JR, Austin JH, Ellis K. Pulmonary sarcoidosis: could mycoplasma-like organisms be a cause? Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1996;13:38-42.
29. Almenoff PL, Johnson A, Lesser M, Mattman LH. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996;51:530-3.
30. Pinner M. Non-caseating tuberculosis. Am Rev Tuberc 1938;36:690-728.
31. Mangiapan G, Hance AJ. Mycobacteria and sarcoidosis: an overview and summary of recent molecular biological data. Sarcoidosis 1995;12:20-37.
32. Miyagawa Y, Mitsuyama T, Hayashi S, Nagata N, Yagawa K, Shigematsu N. A case of pulmonary tuberculosis with bilateral hilar lymphadenopathy diagnosed by sputum culture subsequent to open thoracic biopsy. Respiration 1992;59:247-9.
33. Kent DC, Houk VN, Elliott RC, Sokolowski JW Jr, Baker JH, Sorensen K. The definitive evaluation of sarcoidosis. Am Res Respir Dis 1970;101:721-7.
34. Scadding JG, Mitchell DN. Sarcoidosis. London: Chapman and Hall Medical, 1985.
35. Aberg H. Tuberculosis and sarcoidosis. Acta Tuberc Pneumol Scand 1964;45:84-8.
36. Giotaki HA, Stefanou DG. Biopsy-documented tuberculous pleural effusion in a patient with biopsy-proven coexisting sarcoidosis. Respiration 1988;54:193-6.
37. Knox AJ, Wardman AG, Page RL. Tuberculous pleural effusion occurring during corticosteroid treatment of sarcoidosis. Thorax 1986;41:651.
38. Mankiewicz E. The relationship of sarcoidosis to anonymous bacteria. Acta Med Scand 1964;42S:68-73.
39. Burnet FM. The clonal selection theory of acquired immunity. Cambridge: Cambridge University Press, 1950:160-3.
40. Hanngren A, Biberfeldt G, Carlens E, Hedfors E, Nilsson BS, Ripe E, et al. Is sarcoidosis due to an infectious interaction between virus and mycobacterium? In: Iwai K, Hosoda Y, eds. Proceedings 6th International Conference on Sarcoidosis. Tokyo: University of Tokyo Press, 1974:8-11 (Abstract).
41. Pinkston P, Bitterman PB, Crystal RG. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308:793-800.
42. Hunninghake GW. Role of alveolar macrophage- and lung T cell-derived mediators in pulmonary sarcoidosis. Ann NY Acad Sci 1986;465:82-90.
43. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747-60.
44. Balbi B, Moller DR, Kirby M, Holroyd KJ, Crystal RG. Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis. J Clin Invest 1990;85:1353-61.
45. Balbi B, Valle MT, Oddera S, Giunti D, Manca F, Rossi GA, et al. T-lymphocytes with gamma delta + V delta 2 + antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am Rev Respir Dis 1993;148:1685-90.
46. Taub RN, Sachar D, Siltzbach LE, Janowitz H. Transmission of ileitis and sarcoid granulomas to mice. Trans Assoc Am Physicians 1974;87:219-24.
47. Amicosante M, Paone G, Ameglio E. Bianchi EL, Piccolella F, Richeldi L, et al. Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis. Eur Respir J 1993;6:816-22.
48. Levy H, Feldman C, Wadee AA, Rabson AR. Differentiation of sarcoidosis from tuberculosis using an enzyme-linked immunosorbent assay for the detection of antibodies against Mycobacterium tuberculosis. Chest 1988;94:1254-5.
49. Reutgen H, Pokorny J, Christ R, Ritzau E. [Serum reactivity of antigen fractions of atypical mycobacteria in patients with lung diseases]. Z Erkr Atmungsorgane 1991;177:103-10.
50. Chapman JS, Baum J, Clark J, Speight M. Mycobaeterial antibodies in immunoglobulins IgA and IgM of patients with sarcoidosis. Am Rev Respir Dis 1967;95:612-7.
51. Mitchell IC, Turk JL, Mitchell DN. Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet 1992;339:1015-7.
52. Bocart D, Lecossier D, De Lassence A, Valeyre D, Battesti JP, Hance AJ. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992;145:1142-8.
53. Popper HH, Winter E, Hofler G. DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol 1994;101:738-41.
54. Thakker B, Black M, Foulis AK. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1092;339:1537.
55. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992;339:1012-5.
56. Fidler HM, Rook GA, Johnson NM. McFadden J. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ 1993;306:546-9.
57. Ghossein RA, Ross DG, Salomon RN, Rabson AR. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 1994;101:733-7.
58. Gerdes J, Richter E, Rusch Gerdes S, Greinert V, Galle J. Schlaak M, et al. Mycobacterial nucleic acids in sarcoid lesions. Lancet 1992;339:1536-7.
59. Lisby G, Milman N, Jacobsen GK. Search for Mycobacterium paratuberculosis DNA in tissue from patients with sarcoidosis by enzymatic gene amplification. APMIS 1993;101:876-8.
60. Graham DY, Markesich DC, Kalter DC, Moss MT, Hermon Taylor J, El Zastari FA. Mycobacterial aetiology of sarcoidosis. Lancet 1092;340:52-3.
61. Feingold DS. Biology and pathogenicity of microbial spheroplasts and L-forms. N Engl J Med 1969;281:1159-70.
62. Ratnam S, Chandrasekhar S. The pathogenicity of spheroplasts of Mycobacterium tuberculosis. Am Rev Respir Dis 1976;114:549-54.
63. Mattman LH. Cell wall-deficient forms of mycobacteria. Ann NY Acad Sci 1970;174:852-61.
64. Cantwell ARJ. Histologic observations of variably acid-fast pleomorphic bacteria in systemic sarcoidosis: a report of three cases, Growth 1982;46:113-25.
65. Cantwell AR Jr. Variably acid-fast bacteria in a case of systemic sarcoidosis and hypodermitis sclerodermiformis. Dermatologica 1981;163:239-48.
66. Moscovic EA. Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathol Annu 1978;13Pt 2:69-164.
67. Judge MS, Mattman LH. Cell wall deficient mycobacteria in tuberculosis, sarcoidosis and leprosy. In: Domingue GJ, ed. Cell wall deficient bacteria. Reading, Massachusetts: Addison-Wesley, 1982:257-98.
68. Barth CL, Judge MS, Mattman LH, Hessburg PC. Isolation of an acid-fast organism from the aqueous humor in a case of sarcoidosis. Henry Ford Hosp Med J 1979;27:127-33.
69. Judge MS. Evidence implicating a mycobacterium as the causative agent of sarcoidosis, and comparison of this organism with the blood-borne mycobacterium of tuberculosis. PhD Dissertation, Wayne State University, Detroit, 1979.
70. Alavi HA, Moscovic EA, Immunolocalization of cell-wall-deficient forms of Mycobacterium tuberculosis complex in sarcoidosis and in sinus histiocytosis of lymph nodes draining carcinoma. Histol Histopathol 1996;11:683-94.
71. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1083;5:124-56.
72. Sutherland I. Mycobacteria and sarcoidosis. BCG ineffective against sarcoidosis. BMJ 1003;306:1270.